ask="6.9700"
ask_size="100"
average_daily_volume="32376"
bid="6.2500"
bid_size="2700"
book_value="1.8080"
change="-0.1511"
change_from_200_day_moving_average="-0.5182"
change_from_50_day_moving_average="0.2422"
change_from_52_week_high="-4.0111"
change_From_52_week_low="0.8089"
change_in_percent="-2.2722%"
close="6.4989"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.8600"
ebitda="-9.95M"
eps_estimate_current_year="-0.6200"
eps_estimate_next_quarter="-0.1700"
eps_estimate_next_year="-1.0100"
ex_dividend_date="N/A"
float_shares="8664000"
high="6.6600"
high_52_weeks="10.5100"
last_trade_date="1/30/2017"
last_trade_price="6.4989"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.3700"
low_52_weeks="5.6900"
market_capitalization="86.32M"
moving_average_200_day="7.0171"
moving_average_50_day="6.2567"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.0000"
open="6.6600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-7.3848%"
percent_change_from_50_day_moving_average="+3.8715%"
percent_change_from_52_week_high="-38.1646%"
percent_change_from_52_week_low="+14.2162%"
previous_close="6.6500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.6781"
price_per_sales="70.6091"
revenue="1.25M"
shares_outstanding="13283000"
short_ratio="6.8800"
stock_exchange="NCM"
symbol="ORMP"
volume="19755"
weeks_range_52="5.6900 - 10.5100"
